205 related articles for article (PubMed ID: 30251170)
21. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Yanes T; Young MA; Meiser B; James PA
Breast Cancer Res; 2020 Feb; 22(1):21. PubMed ID: 32066492
[TBL] [Abstract][Full Text] [Related]
22. Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
Raymond VM; Everett JN
Best Pract Res Clin Gastroenterol; 2009; 23(2):275-83. PubMed ID: 19414152
[TBL] [Abstract][Full Text] [Related]
23. Tailoring communication in consultations with women from high risk breast cancer families.
Lobb EA; Butow PN; Meiser B; Barratt A; Gaff C; Young MA; Kirk J; Suthers GK; Tucker K
Br J Cancer; 2002 Aug; 87(5):502-8. PubMed ID: 12189544
[TBL] [Abstract][Full Text] [Related]
24. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
[TBL] [Abstract][Full Text] [Related]
25. A descriptive study of BRCA1 testing and reactions to disclosure of test results.
Lynch HT; Lemon SJ; Durham C; Tinley ST; Connolly C; Lynch JF; Surdam J; Orinion E; Slominski-Caster S; Watson P; Lerman C; Tonin P; Lenoir G; Serova O; Narod S
Cancer; 1997 Jun; 79(11):2219-28. PubMed ID: 9179070
[TBL] [Abstract][Full Text] [Related]
26. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
[TBL] [Abstract][Full Text] [Related]
27. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
28. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
29. Genetic predisposition syndromes and their management.
Euhus DM; Robinson L
Surg Clin North Am; 2013 Apr; 93(2):341-62. PubMed ID: 23464690
[TBL] [Abstract][Full Text] [Related]
30. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
Lewis KM
Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
[TBL] [Abstract][Full Text] [Related]
31. [Psychosocial factors associated with genetic testing for certain hereditary types of neoplasms].
Franková V; Zidovská J; Krutílková V; Havlovicová M; Goetz P
Cas Lek Cesk; 2003; 142(10):599-602. PubMed ID: 14635423
[TBL] [Abstract][Full Text] [Related]
32. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
Hutson SP
Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
[TBL] [Abstract][Full Text] [Related]
33. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
34. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
Pasacreta JV
Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
[TBL] [Abstract][Full Text] [Related]
35. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
[No Abstract] [Full Text] [Related]
36. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
[TBL] [Abstract][Full Text] [Related]
37. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Drohan B; Roche CA; Cusack JC; Hughes KS
Ann Surg Oncol; 2012 Jun; 19(6):1732-7. PubMed ID: 22427173
[TBL] [Abstract][Full Text] [Related]
38. Counseling high-risk women about breast cancer.
LeGrazie B
Oncology (Williston Park); 2011 Feb; 25(2 Suppl Nurse Ed):30-5. PubMed ID: 25373281
[TBL] [Abstract][Full Text] [Related]
39. Psychological Distress and Coping Ability of Women at High Risk of Hereditary Breast and Ovarian Cancer before Undergoing Genetic Counseling-An Exploratory Study from Germany.
Vajen B; Rosset M; Wallaschek H; Baumann E; Schlegelberger B
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33921890
[TBL] [Abstract][Full Text] [Related]
40. Breast Cancer: Genetics and Risk Assessment.
Tejada-Bergés T
Clin Obstet Gynecol; 2016 Dec; 59(4):673-687. PubMed ID: 27749364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
